LifeArc and MRC launch toolkit to navigate medicines repurposing
Medicines repurposing offers new avenues for treating a range of common and rare diseases
Read More
Tag: MRC
NIHR/MRC fund new study of potential genetic roots of ME
The £3.2-million study will investigate whether there are any genetic causes of ME
Read More
LifeArc, MRC create £16m fund to set up gene therapy hubs
The hubs aim to address challenges faced by academics as they seek to advance novel gene therapy research into early stage clinical trials
Read More
NIHR, MRC buddy up to tackle global chronic disease
The organisations announced plans to invest over £6 million in five implementation science projects focused on tackling diabetes and hypertension in low- and middle-income countries.
Read More
New alliance strives to advance human-based drug evaluation
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans to work together on the development of next generation human cell models to advance human based drug discovery.
Read More
Research backs halving chemo after bowel cancer surgery
Some patients receiving chemotherapy after surgery for bowel cancer might only need three months of treatment rather than the six months currently given, according to new research published in Lancet Oncology.
Read More
New test could detect oesophageal cancer years earlier
Scientists have developed a new genetic test that they believe could help diagnose oesophageal cancer up to eight years before symptoms appear in people at a high risk of the disease.
Read More
MRC links with UCB in antibody initiative
The Medical Research Council and UCB have launched a new scheme designed to help accelerate work on the development of antibody-based therapeutics.
Read More
Scottish universities link to develop stem cell therapies
Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve understanding of the biological processes that could form the basis of new therapies to support tissue regeneration or repair.
Read More
UCL research team bags £3.5m MRC grant
A research group from UCL’s Centre for Rheumatology has been awarded a £3.5 million grant from the Medical Research Council (MRC) to advance the development of a novel treatment for anti-phospholipid syndrome (APS) based on UK life sciences group Abzena’s proprietary conjugation technology.
Read More
Cypralis awarded grant to advance acute pancreatitis drug
UK life sciences firm Cypralis has been awarded new funding by Innovate UK to take forward its work on cyclophilin D inhibitors targeting degenerative diseases.
Read More
Government unveils £60m fund for global health research
UK universities can now apply for a share of a five-year, £60-million government fund to underpin research that might ultimately drive benefits to people’s health in low- and middle-income nations.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
